Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(25)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jun 25, 2024 10:13pm
At least the government of Brazil provides a
more meaningful press release than the CEO at Medipharm Labs who can't even provide facts to the shareholders on the 2 drugs approved in Brazil...even after he stated publicly he would do so.
...more
(68)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Jun 25, 2024 12:22pm
RE:RE:Organigram Invests in Germany
Not sure how our partners stack up against Sanity Group. Hoping that they do given the BAT investment in Sanity (and OGI) and their undoubted strategy team doing their DD. If Stada is #2 in
...more
(565)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Jun 25, 2024 11:23am
RE:Organigram Invests in Germany
QC1, especially when considering the following statement in Labs last German update In addition to STADA sales Summary of MediPharm Labs Business Operations in Germany Beacon Medical GMBH
...more
(564)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Jun 25, 2024 9:20am
RE:Organigram Invests in Germany
totally agree with the last sentence especially!!!!!!!! compounded by being partnered with Strada with their connections and ability to bring product to market thru their sales /distribution
...more
(68)
•••
QContinuum1
X
View Profile
View Bullboard History
Post by
QContinuum1
on Jun 25, 2024 9:07am
Organigram Invests in Germany
But this excerpt from the PR is what caught my eye. "The German cannabis industry is poised for significant expansion following the recreational cannabis legal reforms enacted on April 1, 2024
...more
(25)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jun 24, 2024 12:26pm
CEO is extremely greedy and has to go! Sitting on at least
4 drug approvals now, 2 Brazil and 2 U.S. and not giving shareholders any transparency. This greedy POS has to get booted out. ANVISA's drug approval policy clearly states
...more
(123)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Jun 24, 2024 11:39am
RE:RE:Oh how I long for the $10.77 share price when the POCML 4
Oh this hurt, $10,77 i don't beleive that we are going to see forever.
(18)
•••
Lvlchange
X
View Profile
View Bullboard History
Comment by
Lvlchange
on Jun 23, 2024 9:34pm
RE:Oh how I long for the $10.77 share price when the POCML 4
We suck lol.
(18)
•••
Lvlchange
X
View Profile
View Bullboard History
Comment by
Lvlchange
on Jun 23, 2024 9:33pm
RE:Oh how I long for the $10.77 share price when the POCML 4
Brutal... And I'm watching CFL telling myself it's as good as the NFL :-)
(565)
•••
mdjbrown
X
View Profile
View Bullboard History
Post by
mdjbrown
on Jun 23, 2024 11:21am
Oh how I long for the $10.77 share price when the POCML 4
reverse take-over transpired 6 years ago Dare to dream .......... lol https://d1io3yog0oux5.cloudfront.net
...more
(661)
•••
prone
X
View Profile
View Bullboard History
Post by
prone
on Jun 23, 2024 9:57am
This tell the story of why an insider accumulated
-->– Dr. Yasmin Hurd, Mount Sinai Hospital “MediPharm Labs was selected as our preferred provider to participate in this critical study largely based on its team’s deep experience in pharma and
...more
(25)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jun 23, 2024 8:19am
Put down the crack pipe you bum. You really think you
can compete against Canopy's Storz and Bickel in the recreational vaporizer market? Canopy acquired them 6 years ago and you make your move with Remidose now? You're an idiot
...more
(25)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jun 22, 2024 8:48am
Independent of the progress this CEO has to go.
He has accumulated over 30 million shares while keeping shareholders so much so in the dark that even the message board reflects his poor performance with investors having to guess and speculate what
...more
(25)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jun 22, 2024 8:42am
Generic Epidiolex launch and Remidose medical inhaler?
Inhaler delivery method coupled with SEDDS technology provides 2 unique benefits. As already used for asthma, a medical inhaler provides for much faster delivery directly into the blood stream
...more
(565)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Jun 21, 2024 6:11pm
RE:RE:RE:RE:RE:RE:Question ???
“MediPharm Labs was selected as our preferred provider to participate in this critical study largely based on its team’s deep experience in pharma and clinical research, and ability to
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
High-grade gold potential in the world’s best mining jurisdiction
Undervalued Oil & Gas Play Readies for Strong H2 2024 with Canadian and US Assets
How a truck transportation and logistics company leverages acquisitions and technology